Phase 1 Immunotherapy Trial With Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Advanced Solid Tumors

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-3997

Related search